Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial
- Resource Type
- Article
- Authors
- Murai, Kazunori; Ureshino, Hiroshi; Kumagai, Takashi; Tanaka, Hideo; Nishiwaki, Kaichi; Wakita, Satoshi; Inokuchi, Koiti; Fukushima, Toshihiro; Yoshida, Chikashi; Uoshima, Nobuhiko; Kiguchi, Toru; Mita, Masayuki; Aoki, Jun; Kimura, Satoshi; Karimata, Kaori; Usuki, Kensuke; Shimono, Joji; Chinen, Yoshiaki; Kuroda, Junya; Matsuda, Yasufumi; Nakao, Kensuke; Ono, Takaaki; Fujimaki, Katsumichi; Shibayama, Hirohiko; Mizumoto, Chisaki; Takeoka, Tomoharu; Io, Katsuhiro; Kondo, Takeshi; Miura, Masatomo; Minami, Yousuke; Ikezoe, Takayuki; Imagawa, Jun; Takamori, Ayako; Kawaguchi, Atsushi; Sakamoto, Junichi; Kimura, Shinya
- Source
- In The Lancet Haematology December 2021 8(12):e902-e911
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2352-3026